ArticleNeuro-oncology2013

Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.

Chiara Riganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.